Key2Brain AB
559239-8746ActiveDeveloping proprietary technology for next-generation brain targeting therapeutics.
Overview
- 10–19
- Employees
- 2.5–5M SEK
- Revenue
- 2020
- Founded
Description
Key2Brain is a Swedish biotechnology company focused on developing next-generation therapies designed to treat severe diseases affecting the brain. Their core offering is a groundbreaking proprietary technology platform engineered to facilitate efficient uptake and broad distribution of therapeutics...
Tags
Keywords
Company Information
- Industry
- Bioteknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE559239874601
Decision Makers
No decision makers found yet
Similar Companies
20 similar companies in FunnelfeedrAAX Biotech AB
5–9 employeesResearch-driven biotech advancing antibody therapies via proprietary technology.
IRLAB Therapeutics AB
1–4 employeesDeveloping novel CNS drugs for Parkinson's disease using proprietary technology.
Affibody AB
50–99 employeesDeveloping next-generation radiopharmaceuticals using proprietary Affibody technology.
Uppsala Therapeutics AB
0 employeesDeveloping nanoparticle platforms for targeted drug delivery across the BBB.
Grespo AB
0 employeesYoung biomedical company developing CNS treatments based on 2-oxoglutarate research.
Browse More
Key2Brain AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo